Project Grant K99GM166737
- Federal Grant Award Summary The University of Colorado Colorado Springs received a $325,938 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded June 1, 2026, with completion targeted for May 31, 2031. The Klocko Laboratory will conduct fundamental research investigating genome organization and function in fungi, specifically using Neurospora crassa as a model organism to understand...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $387,536 Project Grant to The Regents of the University of Colorado (University of Colorado-Denver) under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025 through August 31, 2029. This four-year grant supports fundamental research to advance understanding of MORF (Monocytic Leukemia Zinc-Finger Protein-Related Factor)-mediated hematological...
- Federal Project Grant Award Summary The University of Denver received a $406,667 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 1, 2026, with completion targeted for December 31, 2030. This grant supports fundamental biomedical research investigating post-transcriptional regulation of tissue regeneration through ribonucleoprotein (RNP) granules, specifically P-bodies. The...
- Federal Project Grant Award Summary The University of Denver received a $407,562 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This award funds fundamental biomedical research investigating the molecular mechanisms of lysosome remodeling in response to cellular stress. The research will advance understanding of how lysosomes—critical...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded University of Colorado-Denver a $1,998,288 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, through August 31, 2029. The award funds investigator-initiated research to develop and apply Co-Translational Folding Tracking (COTFT), a novel technology platform designed to visualize and quantify protein co-translational folding...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Colorado a Project Grant totaling $307,854 under the Biomedical Research and Research Training program (CFDA 93.859) to support fundamental research on RNA Polymerase II transcriptional termination mechanisms. The award, effective April 3, 2026, with a completion date of December 31, 2029, funds investigator-initiated research designed to elucidate how mammalian cells regulate...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Harvard Medical School a Project Grant totaling $647,706 on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports a five-year research initiative through February 28, 2031, led by the Brown Lab to elucidate the molecular mechanisms regulating eukaryotic motile cilia function. The research deliverables include the development of...
- Federal Project Grant Award Summary The University of Colorado-Denver received a $780,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. The award funds fundamental research examining the molecular function and substrate specificity of palmitoyltransferases (PATs)—a family of 24 enzymes in mammals that regulate behavioral responses...
- Federal Project Grant Award Summary The University of Colorado received a $238,819 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2028. The award funds fundamental research investigating the regulation of zinc-dependent lysosome morphological restructuring, zinc trafficking, and low zinc homeostasis mechanisms across Caenorhabditis elegans...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Columbia University's Health Sciences Division a Project Grant of $227,652 under the Biomedical Research and Research Training program (CFDA 93.859) to support research on genome rearrangement mechanisms. The award, issued on June 26, 2026, with a completion date of May 31, 2029, funds a comprehensive investigation titled "Modeling the Cascade of Genome Rearrangements in the Ciliate...
The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant totaling $129,684 under the Biomedical Research and Research Training program (CFDA 93.859) to The Regents of the University of Colorado-Denver, effective July 1, 2026, with a completion date of June 30, 2028. This award supports fundamental research investigating the mechanisms of physiologic DNA damage in multiciliated cells, with particular focus on how these specialized cells amplify centrioles during differentiation. The research addresses a critical gap in understanding how multiciliated cells bypass conventional cell cycle-regulated counting mechanisms to assemble tens to hundreds of centrioles that serve as nucleation sites for motile cilia. The funded research will be conducted under the direction of Dr. Chad Pearson at the University of Colorado and will combine expertise in cell biology with advanced genomics and quantitative microscopy methodologies. The project includes specialized training components in next-generation sequencing techniques and development of a new live-cell imaging system to visualize multiciliated cell differentiation in real-time. These research products will establish a novel research niche examining the independent role of DNA damage signaling in centriole amplification during cell differentiation, with potential implications for understanding developmental processes and cellular dysfunction in respiratory, neurological, and reproductive systems.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $129.7k | 6/12/26 |